AAMI 14971 2019
$140.32
ANSI/AAMI/ ISO 14971:2019 – Medical devices-Application of risk management to medical devices
Published By | Publication Date | Number of Pages |
AAMI | 2019 | 49 |
Specifies a process for a manufacturer to identify the hazards associated with medical devices, including in vitro diagnostic (IVD) medical devices, to estimate and evaluate the associated risks, to control these risks, and to monitor the effectiveness of the controls.
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | ANSI/AAMI/ISO 14971:2019; Medical devices—Application of risk management to medical devices |
3 | Title page |
4 | AAMI Standard Copyright information |
5 | Contents |
6 | Committee representation |
8 | Background of ANSI/AAMI adoption of ISO 14971:2019 |
9 | Foreword |
11 | Introduction |
13 | 1 Scope 2 Normative references 3 Terms and definitions |
19 | 4 General requirements for risk management system 4.1 Risk management process |
21 | Figure 1 — A schematic representation of the risk management process 4.2 Management responsibilities |
22 | 4.3 Competence of personnel 4.4 Risk management plan |
23 | 4.5 Risk management file 5 Risk analysis 5.1 Risk analysis process |
24 | 5.2 Intended use and reasonably foreseeable misuse 5.3 Identification of characteristics related to safety 5.4 Identification of hazards and hazardous situations |
25 | 5.5 Risk estimation 6 Risk evaluation |
26 | 7 Risk control 7.1 Risk control option analysis 7.2 Implementation of risk control measures |
27 | 7.3 Residual risk evaluation 7.4 Benefit-risk analysis 7.5 Risks arising from risk control measures 7.6 Completeness of risk control |
28 | 8 Evaluation of overall residual risk 9 Risk management review 10 Production and post-production activities 10.1 General |
29 | 10.2 Information collection 10.3 Information review 10.4 Actions |
31 | Annex A (informative) Rationale for requirements A.1 General A.2 Rationale for requirements in particular clauses and subclauses A.2.1 Scope |
32 | A.2.2 Normative references A.2.3 Terms and definitions |
33 | A.2.4 General requirements for risk management system A.2.4.1 Risk management process A.2.4.2 Management responsibilities |
34 | A.2.4.3 Competence of personnel A.2.4.4 Risk management plan |
35 | A.2.4.5 Risk management file A.2.5 Risk analysis A.2.5.1 Risk analysis process A.2.5.2 Intended use and reasonably foreseeable misuse A.2.5.3 Identification of characteristics related to safety A.2.5.4 Identification of hazards and hazardous situations |
36 | A.2.5.5 Risk estimation A.2.6 Risk evaluation A.2.7 Risk control A.2.7.1 Risk control option analysis A.2.7.2 Implementation of risk control measures |
37 | A.2.7.3 Residual risk evaluation A.2.7.4 Benefit-risk analysis A.2.7.5 Risks arising from risk control measures A.2.7.6 Completeness of risk control A.2.8 Evaluation of overall residual risk A.2.9 Risk management review |
38 | A.2.10 Production and post-production activities |
39 | Annex B (informative) Risk management process for medical devices B.1 Correspondence between second and third editions Table B.1 — Correspondence between elements of ISO 14971:2007 and ISO 14971:2019 |
41 | B.2 Risk management process overview |
42 | Figure B.1 — Overview of risk management activities as applied to medical devices |
43 | Annex C (informative) Fundamental risk concepts C.1 General Figure C.1 — Pictorial example of the relationship between hazard, sequence of events, hazardous situation and harm (from ISO/IEC Guide 63:2019[2]) |
44 | C.2 Examples of hazards |
45 | Table C.1 — Examples of hazards |
46 | C.3 Examples of events and circumstances Table C.2 — Examples of events and circumstances |
47 | C.4 Examples of relationships between hazards, foreseeable sequences of events, hazardous situations and the harm that can occur |
48 | Table C.3 — Relationship between hazards, foreseeable sequences of events, hazardous situations and the harm that can occur |
49 | Bibliography |